Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Michael O'Riordan

September 18, 2025

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Michael O'Riordan

February 20, 2025

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

L.A. McKeown

April 19, 2023

News Daily News

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Michael O'Riordan

December 20, 2022

News Daily News

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

Michael O'Riordan

December 07, 2022

News Daily News

Eating More Ultraprocessed ‘Junk’ Food Linked to Higher CVD Risk

Michael O'Riordan

March 23, 2021

News Daily News

CV Risk Factors in Youth May Prove Indelible for Later CAD

Marcus A. Banks

July 17, 2019

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

News Daily News

FDA’s Proposed Sodium Reduction Plan Could Have a Big Impact, Analysis Suggests

Todd Neale

April 11, 2018

News Daily News

Maze of Prior Authorization for PCSK9 Inhibitors Poses Challenge to Prescribers

Yael L. Maxwell

January 24, 2018

News Daily News

Synopsis of New Hypertension Guidelines Renews Concerns and Controversy

L.A. McKeown

January 22, 2018

News Daily News

Generic ARBs Linked to Increased Adverse Events

Michael O'Riordan

October 04, 2017

News Daily News

Debating the ARB/MI Paradox: Is It Real, or Is the Story Incomplete?

Michael O'Riordan

June 05, 2017

News Daily News

Global Burden of Elevated Systolic Blood Pressure on the Rise

Michael O'Riordan

January 10, 2017

News Daily News

Beta-Blockers Not Beneficial After PCI for Stable Angina

Michael O'Riordan

August 17, 2016

Advertisement

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

Eating More Ultraprocessed ‘Junk’ Food Linked to Higher CVD Risk

CV Risk Factors in Youth May Prove Indelible for Later CAD

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

FDA’s Proposed Sodium Reduction Plan Could Have a Big Impact, Analysis Suggests

Maze of Prior Authorization for PCSK9 Inhibitors Poses Challenge to Prescribers

Synopsis of New Hypertension Guidelines Renews Concerns and Controversy

Generic ARBs Linked to Increased Adverse Events

Debating the ARB/MI Paradox: Is It Real, or Is the Story Incomplete?

Global Burden of Elevated Systolic Blood Pressure on the Rise

Beta-Blockers Not Beneficial After PCI for Stable Angina

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content